The stock declined 1.07% or $1.99 reaching $183.8 per share. About shares traded. Amgen, Inc. About shares traded. Sensata Technologies Holding N.V. (NYSE:ST) has risen 16.67% since October 13, 2016 and is uptrending. It has underperformed by 11.43% the S&P500. The EVP, Research & Development now owns $11,000,058 of the stock per the Form 4 SEC filing. The company has market cap of $4.38 billion. The Private Capital Management Llc holds 5.45 million shares with $22.72 million value, down from 5.64 million last quarter.
Amgen Inc. has a 12 month low of $133.64 and a 12 month high of $191.10. Volume in the last session has increased compared with TXT's average trading volume. About shares traded. Blackbaud, Inc. It has outperformed by 35.90% the S&P500.
Investors sentiment increased to 1.51 in 2017 Q2. Jackson Grant Investment Advisers Inc. increased its holdings in shares of Amgen by 0.6% during the 1st quarter. Schafer Cullen Mgmt invested in 67,816 shares. 98 funds opened positions while 181 raised stakes. West Coast Finance Limited Liability reported 2,128 shares. Ntv Asset Management Ltd Company reported 0.59% stake. State Board Of Administration Of Florida Retirement stated it has 368,155 shares. The medical research company reported $3.27 EPS for the quarter, topping the consensus estimate of $3.11 by $0.16. Riverhead Lc invested in 47,832 shares or 0.41% of the stock. Ltd. boosted its stake in shares of Amgen by 426.2% in the fourth quarter. Amer Century has 0.31% invested in Amgen, Inc. Cornerstone Advsrs holds 825 shares or 0.06% of its portfolio. Royal Bancshares Of Canada invested 0% in Ecology and Environment (NASDAQ:EEI). On Monday, May 1 Bhanap Nina sold $26,311 worth of QuinStreet Inc (NASDAQ:QNST) or 5,905 shares. $654,015 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was sold by Chodakewitz Jeffrey on Thursday, June 1. $2.50M worth of AbbVie Inc (NYSE:ABBV) shares were sold by CHASE WILLIAM J. Shares for $12.22 million were sold by SMITH IAN F. Also Benzinga.com published the news titled: "3 Reasons To Like Vertex Pharma Shares" on September 29, 2017. (NASDAQ:AMGN) on Wednesday, August 23 with "Buy" rating. Therefore 17% are positive. The rating was maintained by Oppenheimer with "Buy" on Friday, July 21. The firm has "Outperform" rating given on Monday, January 9 by RBC Capital Markets. The rating was downgraded by Pivotal Research to "Sell" on Friday, November 4. On Tuesday, September 1 the stock rating was initiated by Raymond James with "Market Perform". Roth Capital maintained the stock with "Buy" rating in Wednesday, December 9 report. The rating was downgraded by Credit Suisse to "Neutral" on Tuesday, December 20. Oppenheimer maintained the stock with "Buy" rating in Monday, June 5 report. Amgen presently has a consensus rating of "Buy" and an average price target of $186.89. World Asset Management Inc's holdings in Amgen were worth $11,794,000 as of its most recent SEC filing. Cranbrook Wealth Mgmt Limited Liability Company has invested 0.01% in Amgen, Inc. (NASDAQ:AMGN). West Virginia-based United Bancorp has invested 2.02% in Amgen, Inc. (AMGN) Stock Has Plenty More Upside" with publication date: "September 27, 2017.
Investors sentiment decreased to 1.14 in Q2 2017. Its down 0.10, from 1.25 in 2017Q1.
Amgen Inc. (NASDAQ:AMGN)'s latest quote $184.15 $-0.48 -0.88% will find technical support in $182.72 a share and a breakdown below this region would be a significantly bearish signal for Amgen Inc. traders. 100 funds opened positions while 517 raised stakes. (NYSE:TXT) has been 1.25 million shares per day over the past 30 days.
Vikings keep Bradford, 4 other starters out of practice
However, the Vikings will likely be without their top receiver for the third time in the last 12 games dating back to last season. The Minnesota Vikings have five starters with injury concerns going into the game against Green Bay.
04/27/2017 - Amgen Inc. had its "neutral" rating reiterated by analysts at Robert W. Baird. Aberdeen Asset Plc Uk reported 848,944 shares. Moreover, Btim has 0.04% invested in Amgen, Inc. (NASDAQ:AMGN) on Wednesday, May 31. Mariner Wealth Advisors Llc sold 5,821 shares as Amgen Inc (AMGN)'s stock declined 9.68%. (NASDAQ:AMGN) for 350,660 shares. Pinnacle Associates Limited holds 0.26% or 77,491 shares. Beck Mack Oliver holds 6,200 shares. Its down 9.09% from 1,100 shares previously. Finally, Bogart Wealth LLC grew its holdings in shares of Amgen by 13.8% during the 2nd quarter. Regions Fincl Corporation owns 53,479 shares. Aviance Ptnrs Ltd Com stated it has 2.17% of its portfolio in Amgen, Inc. Analysts, on average, seem bullish as they suggest AMGN is worth $5.2 more, giving a target price of $189.35 a share. The Pennsylvania-based Riggs Asset Managment Incorporated has invested 1.86% in Amgen, Inc. Amgen Inc. declared a dividend that was paid on Friday the 8th of September 2017.
Among 13 analysts covering Sensata Technologies Holdings NV (NYSE:ST), 7 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. Abbvie Inc had 60 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has a consensus rating of "Buy" and a consensus price target of $189.99. Additionally, AMGN had a day price range of $182.68 to $185.5. The company was maintained on Thursday, October 29 by UBS. The rating was maintained by SunTrust on Wednesday, October 11 with "Buy". Vetr upgraded Amgen, Inc. The stock of Amgen, Inc. On Friday, December 18 the stock rating was initiated by Atlantic Securities with "Overweight". The firm earned "Buy" rating on Tuesday, July 25 by Oppenheimer.
Since May 24, 2017, it had 0 insider purchases, and 2 selling transactions for $1.02 million activity. Shares for $569,541 were sold by BALTIMORE DAVID on Wednesday, May 31.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.